Clinical Trial Update: A Research Study of House Dust Mite (HDM) SLIT-tablet for the Treatment of HDM Allergy in Chinese Participants Aged 12-65 [Phase 3]

View source ↗

Summary

Phase 3 trial update for a house dust mite SLIT-tablet in Chinese participants with allergic rhinitis/rhinoconjunctivitis is ongoing but not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Allergic Rhinitis
• Allergic Rhinoconjunctivitis

Drugs mentioned

• HDM SLIT tablet (House dust mite allergen extract sublingual immunotherapy tablet)

Snippet

Sponsor: ALK-Abelló A/S | Conditions: Allergic Rhinoconjunctivitis, Allergic Rhinitis | Phase 3 | Status: ACTIVE_NOT_RECRUITING